by Paul Krzyzanowski | Jan 8, 2013
This year, your household will pay $360 for the use of Intellectual Property (IP) held by people and corporations outside of Canada. For a little less than a dollar a day, you’re supporting industries like biotechnology, high-tech electronics, and engineering in other...
by Nick Dragojlovic | Dec 20, 2012
“Stem Cells Make Aging Mice Young Again” – ABC News “’Factor X’ — Have we finally found the fountain of youth?” – Fox News “Stem cells, the secret to eternal youth?” – Euronews.com Headlines like these are all too common and underscore how the news...
by David Brindley | Dec 18, 2012
Some words have the ability to induce instant and unexplained anxiety. In developing industries, such as cell therapy, one such example is regulation – of any sort. Crudely, our negative perception of regulation can be attributed to two factors: an aversion to both...
by Holly Wobma | Dec 12, 2012
When we accidentally burn ourselves while cooking or nick our fingers on a piece of paper, most of us experience a fleeting moment of irritation but never worry that the wound won’t heal. Our everyday lives have taught us that skin is a tissue with great regenerative...
by David Brindley | Nov 30, 2012
The global health care sector is innovative, impactful and, despite addressing fundamental problems in human health, can be inescapably faddish. Despite the industry’s pride in an empirical approach that yields robust and practicable data, the covers of Nature,...
by Angela C. H. McDonald | Nov 27, 2012
Last month, I blogged about recent stem cell advances toward a solution for female infertility. While this post may have left you excited about the potential for stem cells to help women with fertility complications start a family, it may also have left you wondering:...
by Paul Krzyzanowski | Nov 21, 2012
While the 2012 US election was in full swing, I reminded readers that despite the dominance of the world’s economic problems in this cycle, stem cell research was a political issue that hadn’t completely gone away.[pullquote]Ironically, if – and this is a...
by Michael May | Nov 19, 2012
James Till and Ernest McCulloch identified stem cells 50 years ago in Toronto, and their legacy is a vibrant community of scientists who are leaders in this field of research. But what does that mean in terms of producing products and therapies to heal and cure...
by Holly Wobma | Nov 14, 2012
As many of you well know, the U.S. presidential election recently came to a close. Over the last year, there have been numerous speeches from a variety of sources, some of which have been able to rally the masses, due not only to their content but also the speaker’s...
by Nick Dragojlovic | Nov 8, 2012
If you’ve been feeling like you can’t open a web browser these days without finding a story about induced pluripotent stem cells (iPSCs), you’re not alone. Unlike embryonic stem cells, iPSCs are created by directly reprogramming adult cells taken from donors or...
Comments